NCT05655650 · RECRUITING
Identifying Biomarkers in Alzheimer's Disease
This study is looking for biological markers, things measurable in blood, retinal scans, specialized MRI, and PET brain imaging, that could detect Alzheimer's disease earlier and more accurately in Chinese populations. It is an observational study with no phase designation, meaning no drug or treatment is being tested. Researchers are trying to learn whether these tools together can identify who has AD and how far along it has progressed.
You may qualify if
- Chinese ethnicity
- [For dementia group, clinical diagnosis of "probable Alzheimer's disease" according to recommendation from the National Institute on Aging-Alzheimer's Association workgroups (NIA-AA)
You're excluded if
- Clinical diagnosis of non-AD dementia
- contraindication for MRI or PET
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2022-12-19